Beecham's Augmentin launch
Executive Summary
McKesson's PDS market data subsidiary reports that U.S. retail sales of the oral amoxicillin combo "are already approaching $500,000 (at acquisition cost) per week and are expected to increase significantly as the cold season approaches." PDS estimates Beecham has carved out 5% of retail amoxicillin market in "slightly over five weeks"